Detalhe da pesquisa
1.
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.
Int J Cancer
; 145(7): 1935-1945, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860598
2.
Hydrophobic Interaction Chromatography for Bottom-Up Proteomics Analysis of Single Proteins and Protein Complexes.
J Proteome Res
; 16(6): 2318-2323, 2017 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28485144
3.
A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells.
Mol Ther
; 24(2): 298-305, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26581163
4.
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody.
Mol Ther
; 24(9): 1634-43, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380762
5.
High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
Eur J Nucl Med Mol Imaging
; 43(3): 489-98, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341366
6.
Fc-optimized NKG2D-Fc constructs induce NK cell antibody-dependent cellular cytotoxicity against breast cancer cells independently of HER2/neu expression status.
J Immunol
; 193(8): 4261-72, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25217158
7.
Characterization of a bispecific FLT3 X CD3 antibody in an improved, recombinant format for the treatment of leukemia.
Mol Ther
; 23(4): 648-55, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25578618
8.
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.
Proc Natl Acad Sci U S A
; 110(17): 6760-5, 2013 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23569258
9.
An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
Int J Cancer
; 136(5): 1073-84, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25046567
10.
Receptor activator for NF-κB ligand in acute myeloid leukemia: expression, function, and modulation of NK cell immunosurveillance.
J Immunol
; 190(2): 821-31, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23241893
11.
Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.
J Immunol
; 189(3): 1360-71, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22730533
12.
Generation and preclinical characterization of a Fc-optimized GITR-Ig fusion protein for induction of NK cell reactivity against leukemia.
Mol Ther
; 21(4): 877-86, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23380816
13.
4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia.
Eur J Immunol
; 42(3): 737-48, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22144129
14.
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease.
J Hematol Oncol
; 16(1): 96, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587502
15.
An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer.
Cancers (Basel)
; 11(6)2019 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31181683
16.
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia.
J Immunother Cancer
; 7(1): 143, 2019 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142382
17.
Preclinical evaluation of a diabody-based (177)Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model.
Cancer Lett
; 381(2): 296-304, 2016 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27524505
18.
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.
J Immunol Res
; 2015: 561814, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26605343
19.
Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.
PLoS One
; 10(10): e0140471, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26469402
20.
γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay.
Front Immunol
; 5: 618, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25520723